Browsing Tag
HER2 low
1 post
ENHERTU gains FDA approval for HER2 low or ultralow metastatic breast cancer treatment
Daiichi Sankyo and AstraZeneca’s ENHERTU (fam-trastuzumab deruxtecan-nxki) has secured approval from the U.S. Food and Drug Administration (FDA)…